We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $30 · 2 analysts
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Stored first · Google News · Yahoo Finance (English)
IGIC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
IGIC Financials: Revenue Breakdown, Margins & Competitor Comparison Intellectia AI
International General Insurance (IGIC) releases 2025 Financial Condition Report - Stock Titan
International General Insurance (IGIC) releases 2025 Financial Condition Report Stock Titan
May 2026 Dividend Stocks To Consider
Life Insurance In Force of International General Insurance Holdings Ltd. – NASDAQ:IGIC - TradingView
Life Insurance In Force of International General Insurance Holdings Ltd. – NASDAQ:IGIC TradingView
A Look At International General Insurance Holdings (IGIC) Valuation After Its 50% Dividend Increase - simplywall.st
A Look At International General Insurance Holdings (IGIC) Valuation After Its 50% Dividend Increase simplywall.st
Is It Smart To Buy International General Insurance Holdings Ltd. (NASDAQ:IGIC) Before It Goes Ex-Dividend?
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 04. | After market close (AMC) | $0.68 | — | — | — | — | Scheduled |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $1.55 | — | — | $265.77M | Reported |
| FY2024 Q2 | 2023. 06. 30. | Time TBD | — | $1.59 | — | — | $251.23M | Reported |
| FY2023 Q2 | 2022. 06. 30. | Time TBD | — | $0.92 | — | — | $190.46M | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2025. 02. 28. | RBC Capital | — | Maintain | Outperform → Outperform | — | RBC Capital: Outperform |
| 2025. 02. 27. | Oppenheimer | — | Maintain | Outperform → Outperform | — | Oppenheimer: Outperform |
| 2024. 11. 21. | Oppenheimer | — | Initiate coverage | — → Outperform | — | Oppenheimer: Outperform |
| 2024. 11. 08. | RBC Capital | — | Maintain | Outperform → Outperform | — | RBC Capital: Outperform |
| 2024. 08. 09. | RBC Capital | — | Maintain | Outperform → Outperform | — | RBC Capital: Outperform |
| 2024. 03. 15. | RBC Capital | — | Maintain | Outperform → Outperform | — | RBC Capital: Outperform |
As of FY2025Q2 · Source: SEC/DART + price data
No holdings data to show.